MBRX earnings: a positive outcome, +7.5%

On April 26, 2024, Moleculin Biotech, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.5% in the window around the event. It had already run -17.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.